世界の神経刺激装置市場2020-2027:機器種類別(脊髄刺激装置、深部脳刺激装置、仙骨神経刺激装置、迷走神経刺激装置、その他)、用途別、地域別

◆英語タイトル:Global Neurostimulation Device Market Size study, by Device Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Others), by Application (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy, Others) and Regional Forecasts 2020-2027
◆商品コード:BZW20PL161
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年8月11日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、日本、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥656,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、神経刺激装置の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、市場分析、機器種類別(脊髄刺激装置、深部脳刺激装置、仙骨神経刺激装置、迷走神経刺激装置、その他)分析、用途別分析、地域別分析、競争状況、調査プロセスなどを含め、以下の構成でご提供いたします。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・市場分析
・神経刺激装置の世界市場規模:機器種類別(脊髄刺激装置、深部脳刺激装置、仙骨神経刺激装置、迷走神経刺激装置、その他)
・神経刺激装置の世界市場規模:用途別
・神経刺激装置の世界市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Neurostimulation Device Market is valued at approximately USD 4.8 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 12.5% over the forecast period 2020-2027. Neurostimulation devices are surgically implanted devices used in the patient and functioning through thin wires or leads. They are an effective therapeutic solution for pain management on numerous medical conditions, such as diabetic neuropathy or failed back surgery. These devices often help in the electrical stimulation delivered to the intended parts of the patient’s brain, spinal cord, and peripheral nervous system. These devices deliberately carried out via using invasive and non-invasive procedures. Recently, the global burden of the COVID-19 pandemic has led to a rise in demand for neurostimulation devices and other essential medical supplies in identifying or monitoring and diagnosis of the patient’s medical condition to prevent or mitigate the risk of a novel coronavirus, as well as provide optimum care to the patient. This is likely to promote market growth all over the world. Furthermore, these devices are specifically used for the treatment of various diseases, including epilepsy, Parkinson’s disease, chronic pain, and depression. Therefore, the increasing prevalence of diseases, particularly Parkinson’s and epilepsy with a growing geriatric population, and the introduction of technologically advanced neurostimulators are few other factors responsible for the market growth over the forecast period. According to the study of Global Burden of Disease 2015, the global prevalence of Parkinson’s diseases to be approximately 6.2 million people and it would reach almost 13 million people with Parkinson’s by 2040. Also, the Parkinson’s Disease Foundation revealed that nearly 60,000 Americans are diagnosed with Parkinson’s disease every year. This, in turn, is projected to leverage the demand for neurostimulation devices across the globe. However, the presence of strict regulatory guidelines for product-approval and adverse effects and risks related to neurostimulation devices are the major factors impeding the market growth over the forecast period of 2020-2027.

The regional analysis of the global Neurostimulation Device market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing prevalence of neurological disorder, along with the presence of new technology-based solution providers in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the presence of unmet medical needs and the rising incidence of osteoporosis and neurological disorder would create lucrative growth prospects for the Neurostimulation Device market across the Asia-Pacific region.

Major market player included in this report are:
Abbott Laboratories
Aleva Neurotherapeutics SA
Boston scientific corporation
ElectroCore Inc.
EndoStim Inc.
Medtronic plc
NeuroPace Inc.
Nevro Corporation
Neuronetics Inc.
Synapse Biomedical Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Device Type:
Spinal Cord Stimulators
Deep Brain Stimulators
Sacral Nerve Stimulators
Vagus Nerve Stimulators
Others

By Application:
Pain Management
Hearing Loss
Urinary Incontinence
Parkinson’s Disease
Epilepsy
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Neurostimulation Device Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Neurostimulation Device Market, by Region, 2018-2027 (USD Billion)
1.2.2. Neurostimulation Device Market, by Device Type, 2018-2027 (USD Billion)
1.2.3. Neurostimulation Device Market, by Application, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Neurostimulation Device Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Neurostimulation Device Market Dynamics
3.1. Neurostimulation Device Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Neurostimulation Device Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Neurostimulation Device Market, by Device Type
5.1. Market Snapshot
5.2. Global Neurostimulation Device Market by Device Type, Performance – Potential Analysis
5.3. Global Neurostimulation Device Market Estimates & Forecasts by Device Type 2017-2027 (USD Billion)
5.4. Neurostimulation Device Market, Sub Segment Analysis
5.4.1. Spinal Cord Stimulators
5.4.2. Deep Brain Stimulators
5.4.3. Sacral Nerve Stimulators
5.4.4. Vagus Nerve Stimulators
5.4.5. Others
Chapter 6. Global Neurostimulation Device Market, by Application
6.1. Market Snapshot
6.2. Global Neurostimulation Device Market by Application, Performance – Potential Analysis
6.3. Global Neurostimulation Device Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4. Neurostimulation Device Market, Sub Segment Analysis
6.4.1. Pain Management
6.4.2. Hearing Loss
6.4.3. Urinary Incontinence
6.4.4. Parkinson’s Disease
6.4.5. Epilepsy
6.4.6. Others
Chapter 7. Global Neurostimulation Device Market, Regional Analysis
7.1. Neurostimulation Device Market, Regional Market Snapshot
7.2. North America Neurostimulation Device Market
7.2.1. U.S. Neurostimulation Device Market
7.2.1.1. Device Type breakdown estimates & forecasts, 2017-2027
7.2.1.2. Application breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Neurostimulation Device Market
7.3. Europe Neurostimulation Device Market Snapshot
7.3.1. U.K. Neurostimulation Device Market
7.3.2. Germany Neurostimulation Device Market
7.3.3. France Neurostimulation Device Market
7.3.4. Spain Neurostimulation Device Market
7.3.5. Italy Neurostimulation Device Market
7.3.6. Rest of Europe Neurostimulation Device Market
7.4. Asia-Pacific Neurostimulation Device Market Snapshot
7.4.1. China Neurostimulation Device Market
7.4.2. India Neurostimulation Device Market
7.4.3. Japan Neurostimulation Device Market
7.4.4. Australia Neurostimulation Device Market
7.4.5. South Korea Neurostimulation Device Market
7.4.6. Rest of Asia Pacific Neurostimulation Device Market
7.5. Latin America Neurostimulation Device Market Snapshot
7.5.1. Brazil Neurostimulation Device Market
7.5.2. Mexico Neurostimulation Device Market
7.6. Rest of The World Neurostimulation Device Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Abbott Laboratories
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Aleva Neurotherapeutics SA
8.2.3. Boston scientific corporation
8.2.4. ElectroCore Inc.
8.2.5. EndoStim Inc.
8.2.6. Medtronic plc
8.2.7. NeuroPace Inc.
8.2.8. Nevro Corporation
8.2.9. Neuronetics Inc.
8.2.10. Synapse Biomedical Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

TABLE 1. GLOBAL PROGRAMMABLE ROBOTS MARKET, REPORT SCOPE
TABLE 2. GLOBAL PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD MILLION)
TABLE 3. GLOBAL PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY COMPONENT 2017-2027 (USD MILLION)
TABLE 4. GLOBAL PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY APPLICATION 2017-2027 (USD MILLION)
TABLE 5. GLOBAL PROGRAMMABLE ROBOTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 6. GLOBAL PROGRAMMABLE ROBOTS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 7. GLOBAL PROGRAMMABLE ROBOTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 8. GLOBAL PROGRAMMABLE ROBOTS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 9. GLOBAL PROGRAMMABLE ROBOTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 10. GLOBAL PROGRAMMABLE ROBOTS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 11. GLOBAL PROGRAMMABLE ROBOTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 12. GLOBAL PROGRAMMABLE ROBOTS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 13. GLOBAL PROGRAMMABLE ROBOTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 14. GLOBAL PROGRAMMABLE ROBOTS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 15. U.S. PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 16. U.S. PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 17. U.S. PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 18. CANADA PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 19. CANADA PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 20. CANADA PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 21. UK PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 22. UK PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 23. UK PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 24. GERMANY PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 25. GERMANY PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 26. GERMANY PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 27. ROE PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 28. ROE PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 29. ROE PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 30. CHINA PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 31. CHINA PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 32. CHINA PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 33. INDIA PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 34. INDIA PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 35. INDIA PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 36. JAPAN PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 37. JAPAN PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 38. JAPAN PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 39. ROAPAC PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 40. ROAPAC PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 41. ROAPAC PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 42. BRAZIL PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 43. BRAZIL PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 44. BRAZIL PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 45. MEXICO PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 46. MEXICO PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 47. MEXICO PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 48. ROLA PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 49. ROLA PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 50. ROLA PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 51. ROW PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
TABLE 52. ROW PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 53. ROW PROGRAMMABLE ROBOTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
TABLE 54. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL PROGRAMMABLE ROBOTS MARKET
TABLE 55. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL PROGRAMMABLE ROBOTS MARKET
TABLE 56. YEARS CONSIDERED FOR THE STUDY
TABLE 57. EXCHANGE RATES CONSIDERED

FIG 1. GLOBAL PROGRAMMABLE ROBOTS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL PROGRAMMABLE ROBOTS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL PROGRAMMABLE ROBOTS MARKET, KEY TRENDS 2019
FIG 5. GLOBAL PROGRAMMABLE ROBOTS MARKET, GROWTH PROSPECTS 2020-2027
FIG 6. GLOBAL PROGRAMMABLE ROBOTS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL PROGRAMMABLE ROBOTS MARKET, PEST ANALYSIS
FIG 8. GLOBAL PROGRAMMABLE ROBOTS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL PROGRAMMABLE ROBOTS MARKET BY SEGMENT, 2017 & 2027 (USD MILLION)
FIG 10. GLOBAL PROGRAMMABLE ROBOTS MARKET BY SEGMENT, 2017 & 2027 (USD MILLION)
FIG 11. GLOBAL PROGRAMMABLE ROBOTS MARKET BY SEGMENT, 2017 & 2027 (USD MILLION)
FIG 12. GLOBAL PROGRAMMABLE ROBOTS MARKET BY SEGMENT, 2017 & 2027 (USD MILLION)
FIG 13. GLOBAL PROGRAMMABLE ROBOTS MARKET BY SEGMENT, 2017 & 2027 (USD MILLION)
FIG 14. GLOBAL PROGRAMMABLE ROBOTS MARKET, REGIONAL SNAPSHOT 2017 & 2027
FIG 15. NORTH AMERICA PROGRAMMABLE ROBOTS MARKET 2017 & 2027 (USD MILLION)
FIG 16. EUROPE PROGRAMMABLE ROBOTS MARKET 2017 & 2027 (USD MILLION)
FIG 17. ASIA PACIFIC PROGRAMMABLE ROBOTS MARKET 2017 & 2027 (USD MILLION)
FIG 18. LATIN AMERICA PROGRAMMABLE ROBOTS MARKET 2017 & 2027 (USD MILLION)
FIG 19. GLOBAL PROGRAMMABLE ROBOTS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の神経刺激装置市場2020-2027:機器種類別(脊髄刺激装置、深部脳刺激装置、仙骨神経刺激装置、迷走神経刺激装置、その他)、用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆